On January 11th, 2024, the Web of Science database was searched for COVID-19 RNA vaccine-related publications using predetermined search keywords with specific restrictions. Bradford's law was applied to evaluate the core journals in this field. The data was analyzed wi...
Yet here, too, scientists hope that RNA can help get the job done. This approach is called a therapeutic vaccine, meaning it is designed to treat someone who already has cancer, as opposed to a vaccine for preventing disease like COVID-19. But in both cases, the goal is coaxing the r...
This formulation is thermostable when lyophilized, maintaining immunogenicity for at least 6 months at room temperature or standard refrigerated conditions. Taken together, this potent and shelf-stable RNA vaccine platform could be an important contribution to increasing global access to COVID-19 vaccines...
S. Li, X. Ma, L. Zhang, Y. Zhang, W. Yao, X. Liang, J. Zhao, Z. Liu, X. Peng, H. Li, W. Tan, A core-shell structured COVID-19 mRNA vaccine with favorable biodistribution pattern and promising
2022年3月23号,AAHI合作者Corey Casper在BioRxiv上传文章:A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stability,他们开发出一款编码Spike 抗原的自复制新冠mRNA疫苗,利用可冻干且耐温的纳米结构脂质载体NLC...
has recently become the molecule de nos jours. The reason is its role in covid-19 vaccines. The RNA molecules in these encode spike, a coronavirus protein. So, when the protein-making machinery of a body cell encounters such RNA, spike is what it makes. That lets a vaccine-recipient’s...
The coronavirus disease 2019 (COVID-19) messenger RNA (mRNA) vaccines were confirmed to be safe and effective, and the original BNT162b2 mRNA vaccine for children aged 6 months to 4 years was introduced in October 2022. However, COVID-19 vaccination coverage has been low in children, ...
2022年3月23号,AAHI合作者Corey Casper在BioRxiv上传文章:A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stability,他们开发出一款编码Spike抗原的自复制新冠mRNA疫苗,利用可冻干且耐温的纳米结构脂质载体NLC包封samRNA-Spike。在小鼠模型中,证实该款疫苗可以刺激机体产生强烈的体液...
A bivalent COVID-19 mRNA vaccine elicited broad immune responses and protection against Omicron subvariants infection Jun Liu Li Wang Natalia Martin-Orozco ResearchOpen Access10 Jan 2025npj Vaccines Volume: 10, P: 4 Safety and immunogenicity of an optimized self-replicating RNA platform for low dos...
A population-based assessment of myocarditis after messenger RNA COVID-19 booster vaccination among adult recipients We aimed to estimate the rate of myocarditis after the messenger RNA (mRNA) COVID-19 booster vaccination by vaccine type, age, and sex. We used data from t... Z Naveed,J Li...